New Charged Cholinesterase Inhibitors: Design, Synthesis, and Characterization. [PDF]
Mlakić M +7 more
europepmc +1 more source
Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors. [PDF]
Guerguer FZ +6 more
europepmc +1 more source
Investigating the Potency of Erythrina‒Derived Flavonoids as Cholinesterase Inhibitors and Free Radical Scavengers Through in silico Approach: Implications for Alzheimer's Disease Therapy. [PDF]
Akili AWR +4 more
europepmc +1 more source
Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia. [PDF]
Ailabouni NJ +7 more
europepmc +1 more source
Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease. [PDF]
Zuliani G +5 more
europepmc +1 more source
Correction: Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study. [PDF]
Havreng-Théry C +6 more
europepmc +1 more source
Treating Vascular Dementia : Cholinesterase Inhibitors and …
Nagaraja D, Gangadhar B.N.
doaj
Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System [PDF]
Objectives To determine whether initiation of cholinesterase inhibitors is associated with significant weight loss in a real-word clinical setting. Design Retrospective cohort study from 2007 to 2010 comparing weight loss in individuals with dementia ...
Yinghui Miao +2 more
exaly +2 more sources

